Organon (OGN) Operating Margin (2020 - 2026)

Organon (OGN) posted quarterly Operating Margin of 16.1% for Q1 2026, up 30.0% year-over-year from 12.38% in Q1 2025, and up 15.51% on a QoQ basis from 13.93% in Q4 2025.

Organon (OGN) Operating Margin (2020 - 2026) Analysis & Trends

Organon (OGN) has reported Operating Margin for 7 consecutive years, with 16.1% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Operating Margin rose 30.0% year-over-year to 16.1%; the TTM figure through Mar 2026 stood at 18.29% (down 275.0% YoY), while the FY2025 annual figure was 18.19%, up 1556.0% from the prior year.
  • Operating Margin came in at 16.1% for Q1 2026 at Organon, up from 13.93% in the prior quarter.
  • The five-year high for Operating Margin was 25.98% in Q3 2024, with the low at 36.23% in Q4 2023.
  • Average Operating Margin over 5 years is 3.77%, with a median of 7.59% recorded in 2022.
  • Across the five-year window, Operating Margin plunged 1752 bps in 2023 and soared 6100 bps in 2024, its largest moves.
  • Year by year, Operating Margin stood at 32.53% in 2022, then retreated by 11 bps to 36.23% in 2023, then surged by 150 bps to 18.09% in 2024, then decreased by 23 bps to 13.93% in 2025, then rose by 16 bps to 16.1% in 2026.
  • According to Business Quant data, Operating Margin over the past three periods registered 16.1%, 13.93%, and 22.35% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 47.98%
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 26.44%
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 26.60%
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 29.51%
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -47.46%
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 30.94%
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 37.16%
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -286.83%
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 16.10%

Historic Data

Download Data
DateValue
Mar 31, 2026 16.10%
Dec 31, 2025 13.93%
Sep 30, 2025 22.35%
Jun 30, 2025 20.33%
Mar 31, 2025 15.80%
Dec 31, 2024 18.09%
Sep 30, 2024 25.98%
Jun 30, 2024 24.02%
Mar 31, 2024 -26.45%
Dec 31, 2023 -36.23%
Sep 30, 2023 -35.02%
Jun 30, 2023 -24.00%
Mar 31, 2023 -22.43%
Dec 31, 2022 -32.53%
Sep 30, 2022 -17.50%
Jun 30, 2022 -18.99%
Mar 31, 2022 -7.59%
Dec 31, 2021 -22.65%
Sep 30, 2021 -13.75%
Jun 30, 2021 -9.15%